Patents by Inventor Charles A. Baker

Charles A. Baker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9029405
    Abstract: The present invention provides compounds of Formula (I), as selective S1P1 inhibitors, as well as their use for treating multiple sclerosis and other diseases.
    Type: Grant
    Filed: July 6, 2011
    Date of Patent: May 12, 2015
    Assignee: Merck Serono S.A.
    Inventors: Agnes Bombrun, Anna Quattropani, Jerome Gonzalez, Jerome Dorbais, Chris Knight, Charles Baker-Glenn
  • Patent number: 8966126
    Abstract: A method for a multiple port host to communicate with multiple tape drives is provided by requesting information associated with a particular tape. Information is provided that is indicative of availability status of a plurality of host ports. It is determined if there is a traffic load or a reservation load on an active host port. The active host port is reserved if there is not a traffic load or a reservation load on the active host port. Another method receives input indicative of read/write information from at least one tape drive at a host bus adapter. A host port count is increased, and a size of the read/write information is increased until the read/write information is not accepted by the host bus adapter. The host port count is decreased, and the size of the read/write information is decreased until the read/write information is accepted.
    Type: Grant
    Filed: April 10, 2012
    Date of Patent: February 24, 2015
    Assignee: Oracle International Corporation
    Inventors: Charles Baker, Miaohui Zhang, Xiao Li
  • Publication number: 20150051201
    Abstract: Compounds of formula I: or pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3 and A are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
    Type: Application
    Filed: November 3, 2014
    Publication date: February 19, 2015
    Applicant: Genentech, Inc.
    Inventors: Charles Baker-Glenn, Bryan K. Chan, Jennafer Dotson, Anthony Estrada, Timothy Heffron, Joseph Lyssikatos, Zachary Sweeney
  • Publication number: 20150051238
    Abstract: Pyrazole compounds that are modulators of LRRK2, methods of making the compounds, and methods for using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
    Type: Application
    Filed: November 3, 2014
    Publication date: February 19, 2015
    Applicant: GENENTECH, INC.
    Inventors: Charles Baker-Glenn, Daniel Jon Burdick, Bryan K. Chan, Mark Chambers, Huifen Chen, Anthony Estrada, Zachary Kevin Sweeney
  • Publication number: 20150040658
    Abstract: A reference measurement apparatus for a multiphase flow meter comprising: a sampling and measuring chamber coupled to a sampling port via a sample transfer line for extracting the sample having at least one of the gas phase and the liquid phase from the multiphase fluid mixture flowing through the pipe section; a pressure and temperature regulation arrangement arranged to maintain the sample from the sampling port to the sampling and measuring chamber at a pressure/temperature substantially similar to the pressure/temperature of the multiphase fluid mixture flowing through the pipe section; and a second fraction measurement device arranged to estimate a linear attenuation related to the at least one of the gas phase and the liquid phase extracted from the sample, said linear attenuation being used to correct the estimated representative fraction for the at least one of the gas phase and the liquid phase of the multiphase fluid mixture.
    Type: Application
    Filed: July 30, 2012
    Publication date: February 12, 2015
    Applicant: SCHLUMBERGER TECHNOLOGY CORPORATION
    Inventors: Kyrre Aksnes, Sabah Al-Abbas, Andrew Charles Baker, Alexandre Lupeau, Jean-Francois Noel, Rolf Rustad, Lars Seime, Oleg Zhdaneev
  • Patent number: 8939033
    Abstract: Both a flow meter system and method are provided for accurately measuring the percentage amounts of liquid and gas phases in a multiphase flow through a conduit when the liquid phase constitutes a small minority portion (e.g., less than about 20%) of the multiphase flow. The system includes a flow meter that includes a differential pressure sensor connected across a Venturi in the conduit, and a dual energy fraction meter, each of which is operably connected to a digital processor. The system further includes a pump connected to the conduit upstream of the flow meter that introduces at least one pulse of a known quantity of liquid, the pulse being sufficient in volume to temporarily increase the liquid phase by a detectable amount.
    Type: Grant
    Filed: July 20, 2011
    Date of Patent: January 27, 2015
    Assignee: Schlumberger Technology Corporation
    Inventors: Andrew Charles Baker, Cosan Ayan
  • Publication number: 20140371636
    Abstract: What is presented is an ultrasonic waveguide for the transmission of ultrasonic vibrations that establishes a plurality of node and anti-node positions that are each along the ultrasonic waveguide's central axis. The ultrasonic waveguide comprises a waveguide tube, which has both a proximal end and a distal end; a waveguide fitting, which has both a threaded end and a impact surface; and a spring, shock-pulsing mass, and stop. Both the spring and shock-pulsing mass are each positioned on the waveguide tube. Whereas, the stop is positioned on the waveguide tube and it is adapted to non-fixedly engage the spring and shock-pulsing mass. The impact surface of the waveguide fitting is located at an anti-node position, which is along the central axis of the ultra-sonic waveguide when its installed within ultrasonic transducer while in operation.
    Type: Application
    Filed: June 12, 2013
    Publication date: December 18, 2014
    Inventors: Geoffrey Bond, Jeffrey J. Vaitekunas, Charles A. Baker
  • Patent number: 8914553
    Abstract: A multiple port host communicates with multiple tape drives by requesting information associated with a particular tape. Information of availability status of a plurality of host ports is provided. Traversing all host initiator ports finds a host port with no or the least traffic load for a tape reservation request. A host port's traffic load calculation uses instant and the updated historical traffic as primary and secondary factors. Every host port's traffic load is updated for every read/write command, and is used for path selection of reservation requests. The instant load is relatively sensitive but will be zero under light load. The historical load is aware of the light load though it is not sensitive enough when a burst I/O occurs. With the traffic load calculated from instant and historical loads, the distribution of tape tasks is spread evenly among host initiator ports under light load and burst I/O scenarios.
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: December 16, 2014
    Assignee: Oracle International Corporation
    Inventors: Charles Baker, Miaohui Zhang, Xiao Li
  • Publication number: 20140331425
    Abstract: A toilet brush having a handle grip connected to a pull rod which is adapted to travel freely through a hollow main handle. The pull rod is connected at the other end to a cleaning head assembly, having stiff bristles and an absorbent sponge. The sponge is modified to include a scouring surface. The cleaning head assembly is modified to allow any moisture collected by the absorbent sponge to be extracted by pulling on the hollow main handle and the coil spring placing the hollow main handle back to its original position.
    Type: Application
    Filed: December 6, 2013
    Publication date: November 13, 2014
    Inventor: DeAndre Charles Baker
  • Publication number: 20140258579
    Abstract: A multiple port host communicates with multiple tape drives by requesting information associated with a particular tape. Information of availability status of a plurality of host ports is provided. Traversing all host initiator ports finds a host port with no or the least traffic load for a tape reservation request. A host port's traffic load calculation uses instant and the updated historical traffic as primary and secondary factors. Every host port's traffic load is updated for every read/write command, and is used for path selection of reservation requests. The instant load is relatively sensitive but will be zero under light load. The historical load is aware of the light load though it is not sensitive enough when a burst I/O occurs. With the traffic load calculated from instant and historical loads, the distribution of tape tasks is spread evenly among host initiator ports under light load and burst I/O scenarios.
    Type: Application
    Filed: May 20, 2014
    Publication date: September 11, 2014
    Applicant: Oracle International Corporation
    Inventors: Charles Baker, Miaohui Zhang, Xiao Li
  • Patent number: 8815882
    Abstract: Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
    Type: Grant
    Filed: November 9, 2011
    Date of Patent: August 26, 2014
    Assignee: Genentech, Inc.
    Inventors: Charles Baker-Glenn, Daniel Jon Burdick, Mark Chambers, Bryan K. Chan, Huifen Chen, Anthony Estrada, Zachary Kevin Sweeney
  • Patent number: 8809331
    Abstract: Specific Compounds of formula I: or pharmaceutically acceptable salts thereof, wherein m, X, R1, R2, R3, R5, R6 and R7 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
    Type: Grant
    Filed: November 28, 2012
    Date of Patent: August 19, 2014
    Assignee: Genentech, Inc.
    Inventors: Charles Baker-Glenn, Daniel Jon Burdick, Mark Chambers, Bryan K. Chan, Huifen Chen, Anthony Estrada, Janet L. Gunzner-Toste, Daniel Shore, Zachary Kevin Sweeney, Shumei Wang, Guiling Zhao
  • Patent number: 8802663
    Abstract: The present invention relates to pyrazole oxadiazoles derivatives of Formula (I), and their use for treating multiple sclerosis and other diseases, wherein R1, R2 and R3 are as defined in the description.
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: August 12, 2014
    Assignee: Merck Serono SA
    Inventors: Anna Quattropani, Charles Baker-Glenn, Wesley Blackaby, Chris Knight
  • Patent number: 8802674
    Abstract: Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n. X, R1, R2, R3, R5, R6 and R7 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
    Type: Grant
    Filed: December 12, 2012
    Date of Patent: August 12, 2014
    Assignee: Genentech, Inc.
    Inventors: Charles Baker-Glenn, Daniel Jon Burdick, Mark Chambers, Bryan K. Chan, Huifen Chen, Anthony Estrada, Janet Gunzner-Tate, Daniel Shore, Zachary Kevin Sweeney, Shumei Wang, Guiling Zhao
  • Patent number: 8796296
    Abstract: Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein A, X, R1, R2, R3 and R4 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
    Type: Grant
    Filed: November 28, 2012
    Date of Patent: August 5, 2014
    Assignee: Genentech, Inc.
    Inventors: Charles Baker-Glenn, Mark Chambers, Bryan K. Chan, Anthony Estrada, Zachary Kevin Sweeney
  • Patent number: 8791130
    Abstract: Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n. X, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
    Type: Grant
    Filed: November 28, 2012
    Date of Patent: July 29, 2014
    Assignee: Genentech, Inc.
    Inventors: Charles Baker-Glenn, Mark Chambers, Bryan K. Chan, Anthony Estrada, Zachary Kevin Sweeney
  • Patent number: 8769162
    Abstract: A multiple port host communicates with multiple tape drives by requesting information associated with a particular tape. Information of availability status of a plurality of host ports is provided. Traversing all host initiator ports finds a host port with no or the least traffic load for a tape reservation request. A host port's traffic load calculation uses instant and the updated historical traffic as primary and secondary factors. Every host port's traffic load is updated for every read/write command, and is used for path selection of reservation requests. The instant load is relatively sensitive but will be zero under light load. The historical load is aware of the light load though it is not sensitive enough when a burst I/O occurs. With the traffic load calculated from instant and historical loads, the distribution of tape tasks is spread evenly among host initiator ports under light load and burst I/O scenarios.
    Type: Grant
    Filed: December 31, 2012
    Date of Patent: July 1, 2014
    Assignee: Oracle International Corporation
    Inventors: Charles Baker, Miaohui Zhang, Xiao Li
  • Publication number: 20140155373
    Abstract: Compounds of formula (I) described herein are both inhibitors of the phosphodiesterase 4 (PDE4) enzyme and muscarinic M3 receptor antagonists, and are useful for the prevention and/or treatment of diseases of the respiratory tract characterized by airway obstruction.
    Type: Application
    Filed: December 5, 2013
    Publication date: June 5, 2014
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Elisabetta Armani, Gabriele Amari, Mauro Riccaboni, Charles Baker-Glenn
  • Publication number: 20140155428
    Abstract: Compounds of formula (I) defined herein are both inhibitors of the phosphodiesterase 4 (PDE4) enzyme and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of a disease of the respiratory tract characterized by airway obstruction.
    Type: Application
    Filed: December 5, 2013
    Publication date: June 5, 2014
    Applicant: CHIESI FARMACEUTICI S.p.A
    Inventors: Elisabetta ARMANI, Gabriele Amari, Mauro Riccaboni, Charles Baker-Glenn
  • Publication number: 20140155427
    Abstract: Compounds of formula (I) described herein are inhibitors of the phosphodiesterase 4 (PDE4) enzyme and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of diseases of the respiratory tract characterized by airway obstruction.
    Type: Application
    Filed: December 5, 2013
    Publication date: June 5, 2014
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Elisabetta Armani, Gabriele Amari, Mauro Riccaboni, Andrea Rizzi, Charles Baker-Glenn, Wesley Blackaby, Herve' Van de Poel, Ben Whittaker